Wrap Text
Audited results for the year ended 31 March 2026
Omnia Holdings Limited
(Incorporated in the Republic of South Africa)
Registration number 1967/003680/06
JSE code: OMN
LEI NUMBER: 529900T6L5CEOP1PNP91
ISIN: ZAE000005153
(Omnia or the company)
AUDITED RESULTS FOR THE YEAR ENDED 31 MARCH 2026
"Omnia delivered a strong FY26 performance, demonstrating disciplined execution in a complex operating environment.
This was driven by strong volume and margin growth, supported by the strengthening competitiveness of our core
businesses, with both Agriculture and Mining contributing robust earnings, margins and solid cash generation.
By combining operational excellence with a targeted diversification strategy, we have positioned the Group to capture
high-quality growth opportunities while maintaining capital efficiency and cost discipline. Looking ahead, we are well
positioned to accelerate growth across our core markets, supported by favourable structural demand in both the
agricultural and mining sectors. Our strategic priorities remain clear: scaling our international business, deploying
capital with discipline, and driving superior returns through customer-led innovation, resilient supply chains,
and high-performance manufacturing. At the same time, we remain committed to operating as a safe and responsible business,
advancing food security, supporting economic development, and promoting the responsible use of resources. With a strong
balance sheet and a clear growth trajectory, we are confident in our ability to deliver sustainable long-term value for
our stakeholders." Seelan Gobalsamy (Group CEO)
FINANCIAL INDICATORS
- Revenue increased 6% to R24 200 million (FY25: R22 818 million)
- Operating profit increased 28% to R2 170 million (FY25: R1 698 million)
- Operating margin increased 21% to 9.0% (FY25: 7.4%)
- EBITDA(2) increased 21% to R2 775 million (FY25: R2 302 million)
- Earnings per share (EPS) increased 24% to 861 cents (FY25: 692 cents)
- Headline earnings per share (HEPS) increased 21% to 849 cents (FY25: 704 cents)
- Disciplined net working capital management of R3 751 million (FY25: R3 426 million)
- Strong net cash position(3) of R1 678 million (FY25: R1 770 million)
- Net asset value increased to R10 759 million (FY25: R10 428 million)
- Ordinary dividend declared(1) increased 18% to 470 cents (FY25: 400 cents)
- Special dividend declared of 280 cents (FY25: 275 cents)
(1) An announcement relating to the salient dates and the tax treatment of the ordinary and special dividend will be
released on SENS.
(2) EBITDA is a Non-IFRS measure. Excludes impairments of R34 million (FY25: R13 million).
(3) Excluding lease liabilities.
ESG HIGHLIGHTS
- Recordable case rate (number of recordable cases or injuries relative to 200 000 working/exposure hours)
decreased to 0.16 (FY25: 0.20)
- CO2 intensity (per tonne manufactured) decreased to 0.047 (FY25: 0.050)
- Renewable energy use (solar generation output MWh) increased to 24 183 (FY25: 20 109)
- Energy use efficiency (net) (gigajoules per tonne manufactured) improved to 0.25 (FY25: 0.26)
- Water use efficiency (kilolitres per tonne manufactured) stable at 0.40 (FY25: 0.40)
- B-BBEE rating maintained at Level 2 (FY25: Level 2)
- Global Credit Rating long term maintained: A+ short term: A1 both with stable outlook
(FY25: long term A+ short term: A1 both with stable outlook)
AGRICULTURE
- Revenue increased 13% to R13 053 million
- Operating profit increased 28% to R1 251 million
- Operating margin increased 13% to 9.6%
The Agriculture segment delivered a strong performance with volume, earnings and margin growth, driven by
customer-centric execution. The Group's integrated manufacturing and supply chain capabilities continued
to be a key enabling differentiator.
In South Africa, the Nutriology model remained central to customer engagement, combining scientific
crop nutrition with specialised on-farm advisory support. Agriculture RSA achieved increased volumes at higher
average prices, but the impact of the extended supplier shutdowns on manufacturing recoveries and a non-recurring asset
sale in FY25 resulted in comparatively lower operating profit and margin. The Rest of Africa delivered a strong
performance, underpinned by volume recovery and improved margins in Zambia and Zimbabwe from improved trading conditions.
Disciplined execution of operating model changes in the division and currency gains in Zambia supported performance.
Agriculture International delivered a mixed performance, with increased biostimulant exports and strong production
volumes in Australia being offset by currency volatility and a subdued performance in Brazil. Volumes increased in the
USA as the business progressed its shift towards a scalable distribution model.
The Agriculture segment is well positioned to deliver sustainable earnings, supported by its differentiated offerings
and strong market positions despite a more complex operating environment. Omnia's integrated manufacturing and supply
chain capabilities continue to strengthen operational resilience through focus on plant efficiency and utilisation.
In South Africa, farmer affordability is under pressure from higher input costs, however, Omnia's Nutriology model
will continue to support operational resilience and customer value. In the Rest of Africa, where the environment is
expected to remain complex, the business is well positioned to expand its retail footprint and distribution partner
network. The International business is expected to deliver growth, supported by the expansion of its biostimulants
offering and wholesale distribution footprint across existing and new markets.
MINING
- Revenue increased 8% to R9 816 million
- Operating profit increased 1% to R1 145 million
- Operating margin decreased 6% to 11.7%
The Mining segment delivered a resilient performance from volume growth and product mix enhancements, in a complex
operating environment. Operating profit increased despite significant currency volatility in Zambia and mobilisation
costs to progress the international growth strategy. Omnia's integrated manufacturing and supply chain capabilities
supported reliable supply to customers, while technology propositions were enhanced through partnerships.
Mining South Africa's volumes increased due to strong demand in the iron ore and platinum markets, contract extensions
and organic growth. This was offset by the downturn in the diamond market, volatility in the coal sector and higher
rainfall. Volume growth supported higher earnings while margin came under pressure from higher input costs. Mining
International's revenue increased from strong demand in SADC, however operating profit and margin were impacted by a
significant currency loss in Zambia. In West Africa, Mali continued to demonstrate strong demand, while overall
volumes were down due to the suspension of operations in other jurisdictions. Indonesia contributed positively to the
overall performance despite mine license related contract curtailments. In Canada, all initiating systems plants have
been commissioned. The strategic partnership with Hypex Bio has progressed well with the hydrogen peroxide emulsion
plant being cold commissioned. In Australia, the AXXIS electronic detonator assembly plant has been commissioned and
in-country manufacturing commenced. BME Metallurgy delivered strong results driven by its customer value proposition
and product mix enhancements.
The Mining segment remains well positioned to deliver sustainable growth in a complex operating environment through
diversification and by leveraging innovation, technology partnerships and operational excellence. The segment's
geographic footprint, investment for international growth, integrated manufacturing and supply chain capabilities and
long-standing customer relationships provide resilience and flexibility. In South Africa, the outlook remains positive
and focused on driving organic growth. Demand across SADC is expected to remain robust, particularly in copper, uranium
and battery-related minerals. In West Africa, BME is repositioning its footprint in select markets, and growth in
Indonesia is expected to be supported by diversifying into metal commodities and differentiated technologies. In
Australia, detonator production will underpin volume growth and strengthen BME's competitive positioning. In Canada
underground trials and commercialisation of the Hypex Bio technology is expected to unlock growth. BME Metallurgy is well
positioned to benefit from favourable uranium market fundamentals, ammonia derivative demand and an improved product mix.
CHEMICALS
- Revenue decreased 38% to R1 331 million
- Operating profit increased more than 100% to R4 million
- Operating margin increased more than 100% to 0.3%
The Chemicals segment continued to execute its strategy to streamline the business, release capital and sustainably
improve financial performance. The rationalisation of unprofitable product lines was completed and associated sites
closed. The Bulk Trade business benefited from ammonia derivatives sales and a stronger demand for bulk liquids.
Water Care delivered a substantial improvement in profitability, supported by new contract wins and improved margins
despite raw material shortages and logistics disruptions.
South Africa's industrial sector outlook is cautiously optimistic with potential growth supported by improved energy
availability, port and rail logistics and market demand, underpinning the demand for industrial chemicals.
Further asset disposals are expected, while the business will continue to explore the sale of the profitable
Water Care business. The continued scaling of the Bulk Trade business through leveraging Omnia's supply chain
capability is expected to deliver sustainable returns.
SOUTH AFRICAN REVENUE SERVICE (SARS)
On 30 September 2022, SARS partially allowed our objection to the additional tax assessments raised in respect of the
Group's 2014 to 2016 years of assessment, resulting in a nominal reduction in the original tax assessments raised by
SARS. The Group disagrees with SARS' findings and appealed the revised assessments, Alternative Dispute Resolution
(ADR) proceedings commenced in FY24, and are ongoing. ADR proceedings are at an advanced stage, with a decision on the
next steps expected in the near term. Should the ADR process not result in a satisfactory resolution, the Group will
advance its appeal by seeking adjudication by the courts if necessary.
Executive directors: T Gobalsamy (Group CEO), S Serfontein (finance director)
Non-executive directors: T Eboka (chair), Prof N Binedell, G Cavaleros, T Mokgosi-Mwantembe, W Plaizier (Dutch), R van Dijk
Company secretary: D Dickson
JSE sponsor: Java Capital
Date of announcement: 8 June 2026
SHORT FORM ANNOUNCEMENT
This announcement is the responsibility of the directors and is only a summary of information in the audited
consolidated annual financial statements for the year ended 31 March 2026 of Omnia Holdings Limited and its
subsidiaries (FY26 AFS) and does not contain full or complete details. Any investment decisions by investors
and/or shareholders should be based on the FY26 AFS which were published on SENS on 8 June 2026 and which are
available at the following link: https://senspdf.jse.co.za/documents/2026/JSE/ISSE/OMN/FY2026.pdf and published
on the company's website on the following link:
https://omnia.co.za/media/omnia-annual-financial-results-long-form-FY2026.pdf
The FY26 AFS, including the audit opinion of the external auditor, Deloitte & Touche, which sets out the key
audit matter and basis of its unmodified opinion, are available on the company's website on:
https://omnia.co.za/media/omnia-audited-annual-financial-statements-FY2026.pdf
This announcement itself is not audited, but is extracted from the FY26 AFS. Omnia also voluntarily publishes
supplementary information to the FY26 AFS, which includes, inter alia, directors' commentary and outlook and
is available on the company's website at the following link:
https://omnia.co.za/media/omnia-annual-financial-results-long-form-FY2026.pdf
www.omnia.co.za
Date: 08-06-2026 07:05:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
Sharenet Sites 
